09:50 AM EST - Amorfix Life Sciences Ltd. : has completed the optimization of the EP-AD Alzheimer's disease diagnostic and will seek a strategic partner for further development and commercialization of the assay. Amorfix Life Sciences Ltd.
shares T.AMF are trading up $0.02 at $0.05.
